eflornithine has been researched along with Multiple Primary Neoplasms in 2 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Halberg, RB | 1 |
Katzung, DS | 1 |
Hoff, PD | 1 |
Moser, AR | 1 |
Cole, CE | 1 |
Lubet, RA | 1 |
Donehower, LA | 1 |
Jacoby, RF | 1 |
Dove, WF | 1 |
Rao, CV | 1 |
Tokumo, K | 1 |
Rigotty, J | 1 |
Zang, E | 1 |
Kelloff, G | 1 |
Reddy, BS | 1 |
2 other studies available for eflornithine and Multiple Primary Neoplasms
Article | Year |
---|---|
Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers.
Topics: Adenoma; Animals; Eflornithine; Female; Fibromatosis, Aggressive; Genes, APC; Genes, p53; Intestinal | 2000 |
Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination.
Topics: Animals; Body Weight; Colonic Neoplasms; Dehydroepiandrosterone; Drug Combinations; Drug Evaluation, | 1991 |